Kwality Pharma — 360° view

Kwality Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹181 crore and net profit of ₹29 crore for the September 2026 quarter.

Kwality Pharma (NSE: KPL) closed at ₹4,128.40 on 20 Nov 2026. Its market capitalisation is ₹4,284 crore and it trades at 44.4 times earnings.

Share price
₹4,128.40 (20 Nov 2026)
Market cap
₹4,284 Cr (20 Nov 2026)
P/E
44.37 (20 Nov 2026)
Revenue
₹181 Cr (September 2026 quarter)
Net profit
₹29 Cr (September 2026 quarter)
ROCE
24.1% (FY26)
ROE
22.6% (FY26)
Book value
₹372 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹4,299.00 / ₹1,561.00 (20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: KPL

Incorporated in 1983, Kwality Pharma is in the business of manufacturing & trading in Pharmaceuticals & allied products

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.